Skip to content
Stop using now Drug recall · FDA · Published February 14, 2024

Golden State Medical Recalls Fluticasone Nasal Spray for Bacterial Risk

Golden State Medical Supply recalls Fluticasone Propionate Nasal Spray due to suspected Burkholderia cepacia contamination. Check lot TX5275.

🇺🇸 FDA recall #D-0349-2024DrugGolden State Medical Supply ›
Take action

Contact the company

Recalling firmGolden State Medical Supply Inc.5187 Camino Ruiz · Camarillo, CA 93012-8601
✎ GovInfoNow plain-language explainer

Golden State Medical Supply Inc. is recalling Fluticasone Propionate Nasal Spray USP because of Good Manufacturing Practice (CGMP) deviations that suggest a potential presence of Burkholderia cepacia complex bacteria. The affected product contains 120 metered sprays and was manufactured by Apotek Inc. in Toronto, Ontario, Canada. This recall affects approximately 59,712 bottles distributed nationwide in the USA. Read more at govinfonow.com/recall/32818-golden-state-medical-recalls-fluticasone-nasal-spray-for-bacterial-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32818-golden-state-medical-recalls-fluticasone-nasal-spray-for-bacterial-risk · Updated October 9, 2026 · FDA enforcement record: FDA #D-0349-2024

Cite this page

“Golden State Medical Recalls Fluticasone Nasal Spray for Bacterial Risk.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32818-golden-state-medical-recalls-fluticasone-nasal-spray-for-bacterial-risk. Based on FDA recall #D-0349-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0349-2024%22&limit=1).

The FDA announced on Feb. 14, 2024, that Golden State Medical Supply Inc. is recalling Fluticasone Propionate Nasal Spray due to suspected potential presence of Burkholderia cepacia complex from CGMP deviations. Owners should contact the company for a refund.

How to tell if you have it

  • Brand: Golden State Medical Supply
  • Product: Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill
  • NDC: 60429-195-15
  • Lot #: TX5275
  • Exp. Date: 10/31/2026
  • Quantity: 59,712 bottles

The hazard

The recall addresses CGMP deviations involving the suspected potential presence of Burkholderia cepacia complex in the nasal spray.

Context

GovInfoNow's records show Golden State Medical Supply Inc. has 31 other recalls on record since April 14, 2014. Other recent recalls of similar products include ClearLife Allergy Nasal Spray (Dec. 12, 2025), Walgreens Saline Nasal Spray with Xylitol (Nov. 12, 2025), and Beekeeper's Naturals Saline Nasal Spray (June 1, 2026).

How to tell if you have this one

Check your nasal spray bottle for the National Drug Code (NDC) 60429-195-15. Verify that the Lot Number is TX5275 and the Expiration Date is 10/31/2026. The product contains 50 mcg per spray, 120 metered sprays, and has a 16 g net fill.

  • Brand
    Golden State Medical Supply
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the nasal spray

    Do not use any Fluticasone Propionate Nasal Spray USP with Lot # TX5275 due to the suspected bacterial contamination.

  2. Dispose of or return the product

    The recall record does not specify a remedy, return process, or refund procedure; contact your pharmacy or healthcare provider for guidance on disposal and replacement.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 21 days after the firm started it.

1. Firm started the recall: Feb 14, 202412. FDA classified it Class II: Feb 23, 202423. Published in FDA’s Enforcement Report: Mar 6, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Golden State Medical Supply recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0349-2024 (February 14, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0349-2024 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA